Investment
Features
FeesSafety
Academy
More
Pluang+

Compare iShares MSCI United Kingdom (FTSE) (EWU) vs UiPath Inc (PATH) Price & Performance

iShares MSCI United Kingdom (FTSE)Trade
UiPath IncTrade

Price performance (Past 24H)

Key statistics

iShares MSCI United Kingdom (FTSE) vs UiPath Inc — how do they compare? iShares MSCI United Kingdom (FTSE) trades at $46.75, while UiPath Inc trades at $11.48 (market cap $6.19B). The key difference: iShares MSCI United Kingdom (FTSE) is trading nearer its 52-week high, UiPath Inc nearer its low. Which is the better fit depends on your goals.

EWUPATH
Sector
Broad Market / FactorTechnology
52-Week High
$48.68$19.29
52-Week Low
$39.80$9.38
Market Cap
$6.19B
Enterprise Value
$4.97B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

iShares MSCI United Kingdom (FTSE)

No Aura AI signal available yet.

UiPath Inc

UiPath (PATH) trades at $11.94, up 0.76% with a bullish technical outlook and strong support at $11. The company shows improving fundamentals with revenue growing from $1.43B in 2025 to projected $1.7B in 2026, while transitioning from losses to profitability. Recent earnings show mixed results with Q2 2026 expectations at $0.15 EPS. The stock trades below analyst consensus target of $13.33, representing potential upside from current levels.

PATH presents a compelling turnaround story with improving profitability and strong gross margins above 80%. Key risks include execution challenges in AI monetization and competitive pressures in enterprise automation. The 25% upside to consensus target and improving cash flow trends support a constructive outlook, though investors should monitor Q2 earnings delivery and enterprise adoption of Maestro AI capabilities.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About iShares MSCI United Kingdom (FTSE)

EWU is a country-specific ETF that tracks the performance of the United Kingdom equity market. It provides exposure to large and mid-sized UK companies, with significant weightings in financials, energy, and healthcare, including Shell, AstraZeneca, and HSBC.

Read more on EWU

About UiPath Inc

UiPath Inc creates an end-to-end platform that provides automation with user emulation at its core. Its platform is built to be used by employees throughout a company and to address a wide variety of use cases, from simple tasks to long-running, complex business processes. It generates revenue from the sale of licenses for its proprietary software, maintenance and support, and professional services. It generates a majority of the revenues from the US, followed by Romania and the rest of the world.

Read more on PATH